Indications |
Oral Cough suppressant Adult: 60 mg tid for not >7 days. Child: >2 yr: 1 mg/kg tid; >12 yr: 60 mg tid. Treatment duration: Not >7 days. |
Contraindications |
Excessive mucus discharge and limited mucociliary function. Severe liver impairment. |
Warnings / Precautions |
Severe renal insufficiency. May impair ability to drive or operate machinery. Child <2 yr. |
Adverse Reactions |
Nausea, vomiting, heartburn, diarrhoea, fatigue, weakness, drowsiness, dizziness, headache, palpitations. |
Drug Interactions |
Additive sedation with sedatives and alcohol. See Below for More levodropropizine Drug Interactions |
Mechanism of Actions |
Levodropropizine is a cough suppressant that exerts peripheral action in nonproductive cough. Absorption: Rapidly absorbed from the GI tract (oral); peak plasma concentrations in 40 min. Distribution: Protein-binding: 13%. |
Administration |
Should be taken on an empty stomach. (Take between meals.) |
Storage Conditions |
Oral: Store below 30°C (86°F). |
ATC Classification |
R05DB27 - levodropropizine ; Belongs to the class of other cough suppressants. |
Storage |
Oral: Store below 30°C (86°F). |
Available As |
|
Levodropropizine
Post Review about Levodropropizine Click here to cancel reply.
Levodropropizine Containing Brands
Levodropropizine is used in following diseases
Drug - Drug Interactions of Levodropropizine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.